These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 31109983)

  • 21. The impact of variation in renal replacement therapy settings on piperacillin, meropenem, and vancomycin drug clearance in the critically ill: an analysis of published literature and dosing regimens*.
    Jamal JA; Udy AA; Lipman J; Roberts JA
    Crit Care Med; 2014 Jul; 42(7):1640-50. PubMed ID: 24674926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug Dosing Considerations in Critically Ill Patients Receiving Continuous Renal Replacement Therapy.
    Jang SM; Infante S; Abdi Pour A
    Pharmacy (Basel); 2020 Feb; 8(1):. PubMed ID: 32046092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic/pharmacodynamic considerations for the optimization of antimicrobial delivery in the critically ill.
    Tsai D; Lipman J; Roberts JA
    Curr Opin Crit Care; 2015 Oct; 21(5):412-20. PubMed ID: 26348420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial Disposition During Pediatric Continuous Renal Replacement Therapy Using an Ex Vivo Model.
    Purohit PJ; Elkomy MH; Frymoyer A; Sutherland SM; Drover DR; Hammer GB; Su F
    Crit Care Med; 2019 Sep; 47(9):e767-e773. PubMed ID: 31306179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tigecycline in critically ill patients on continuous renal replacement therapy: a population pharmacokinetic study.
    Broeker A; Wicha SG; Dorn C; Kratzer A; Schleibinger M; Kees F; Heininger A; Kees MG; Häberle H
    Crit Care; 2018 Dec; 22(1):341. PubMed ID: 30558639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy.
    Economou CJP; Wong G; McWhinney B; Ungerer JPJ; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2017 May; 49(5):589-594. PubMed ID: 28341612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of renal replacement therapy on pharmacokinetics in critically ill patients.
    Bugge JF
    Best Pract Res Clin Anaesthesiol; 2004 Mar; 18(1):175-87. PubMed ID: 14760881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Principles of antibacterial dosing in continuous renal replacement therapy.
    Choi G; Gomersall CD; Tian Q; Joynt GM; Freebairn R; Lipman J
    Crit Care Med; 2009 Jul; 37(7):2268-82. PubMed ID: 19487930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of pharmacokinetic studies in critically ill patients receiving continuous renal replacement therapy.
    Vaara S; Pettila V; Kaukonen KM
    Acta Anaesthesiol Scand; 2012 Feb; 56(2):147-57. PubMed ID: 22092254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and Pharmacodynamics of Antimicrobials in Critically Ill Patients.
    Owen EJ; Gibson GA; Buckman SA
    Surg Infect (Larchmt); 2018; 19(2):155-162. PubMed ID: 29272204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of continuous renal replacement therapy on antibiotic pharmacokinetics in critically ill patients.
    Fiore M; Peluso L; Taccone FS; Hites M
    Expert Opin Drug Metab Toxicol; 2021 May; 17(5):543-554. PubMed ID: 33733979
    [No Abstract]   [Full Text] [Related]  

  • 32. [Dose adjustment of anti-infective drugs in patients with renal failure and renal replacement therapy in intensive care medicine : Recommendations from the renal section of the DGIIN, ÖGIAIN and DIVI].
    Czock D; Schwenger V; Kindgen-Milles D; Joannidis M; John S; Schmitz M; Jörres A; Zarbock A; Oppert M; Kielstein JT; Willam C
    Med Klin Intensivmed Notfmed; 2018 Jun; 113(5):384-392. PubMed ID: 29546450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Practical considerations for individualizing drug dosing in critically ill adults receiving renal replacement therapy.
    Kanji S; Roger C; Taccone FS; Muller L
    Pharmacotherapy; 2023 Nov; 43(11):1194-1205. PubMed ID: 37491976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selecting antibacterials for outpatient parenteral antimicrobial therapy : pharmacokinetic-pharmacodynamic considerations.
    Slavik RS; Jewesson PJ
    Clin Pharmacokinet; 2003; 42(9):793-817. PubMed ID: 12882587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimizing Pharmacokinetics-Pharmacodynamics of Antimicrobial Management in Patients with Sepsis: A Review.
    Phe K; Heil EL; Tam VH
    J Infect Dis; 2020 Jul; 222(Suppl 2):S132-S141. PubMed ID: 32691832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Continuous renal replacement therapies (CRRT) will remain the most widely adopted dialysis modality in the critically ill].
    Morabito S; Pistolesi V; Cibelli L; Pierucci A
    G Ital Nefrol; 2009; 26(1):13-21. PubMed ID: 19255959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Harmonizing antibiotic regimens with renal replacement therapy.
    Jang SM; Lewis SJ; Mueller BA
    Expert Rev Anti Infect Ther; 2020 Sep; 18(9):887-895. PubMed ID: 32362161
    [No Abstract]   [Full Text] [Related]  

  • 38. Dosing of antibiotics in critically ill patients undergoing renal replacement therapy.
    Kielstein JT; Burkhardt O
    Curr Pharm Biotechnol; 2011 Dec; 12(12):2015-9. PubMed ID: 21554216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug dosing considerations in continuous renal replacement therapy.
    Jang SM; Awdishu L
    Semin Dial; 2021 Nov; 34(6):480-488. PubMed ID: 33939855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Higher renal replacement therapy dose delivery influences on drug therapy.
    Mueller BA; Pasko DA; Sowinski KM
    Artif Organs; 2003 Sep; 27(9):808-14. PubMed ID: 12940903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.